Charles D. Ebert
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Dermatology top 5%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Papers in
-
- Advancements in Transdermal Drug Delivery 3
- Advanced Drug Delivery Systems 2
-
- Glycosylation and Glycoproteins Research 1
- Protein purification and stability 1
- Co-authors
- Sung Wan Kim (4 shared papers)Bret Berner (2 shared papers)Gerard C. Mazzenga (2 shared papers)Shuji Sato (1 shared paper)Wim E. Hennink (1 shared paper)Jan Feijén (1 shared paper)Jie Zhang (1 shared paper)Theodore H. Stanley (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Thrombosis Research (2 papers)International Journal of Pharmaceutics (1 paper)Annals of the New York Academy of Sciences (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Charles D. Ebert
10 papers receiving 475 citations
Peers
Comparison fields: 5 of 84
- Pharmaceutical Science 268
- Dermatology 96
- Surfaces, Coatings and Films 56
- Biomaterials 91
- Molecular Medicine 23
Countries citing papers authored by Charles D. Ebert
This map shows the geographic impact of Charles D. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Ebert more than expected).
Fields of papers citing papers by Charles D. Ebert
This network shows the impact of papers produced by Charles D. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Ebert. The network helps show where Charles D. Ebert may publish in the future.
Co-authors
The 14 scholars most cited alongside Charles D. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 162 | |
| 2 | 1982 | 75 | |
| 3 | 1983 | 69 | |
| 4 | 1983 | 55 | |
| 5 | 1994 | 51 | |
| 6 | 1989 | 45 | |
| 7 | 1980 | 28 | |
| 8 | 1999 | 27 | |
| 9 | 1983 | 15 | |
| 10 | 2019 | 1 |
About Charles D. Ebert
Charles D. Ebert is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Cell Biology and Organic Chemistry, having authored 10 papers that have together received 528 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (3 papers), Dermatology and Skin Diseases (2 papers), Advanced Drug Delivery Systems (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Blood properties and coagulation (1 paper), Glycosylation and Glycoproteins Research (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Pharmaceutical Science (268 citations), Dermatology (96 citations), Surfaces, Coatings and Films (56 citations), Biomaterials (91 citations) and Molecular Medicine (23 citations). Charles D. Ebert has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include Sung Wan Kim, Bret Berner, Gerard C. Mazzenga, Shuji Sato, Wim E. Hennink, Jan Feijén, Jie Zhang, Theodore H. Stanley, James C. McRea and Jindŕich Kopec̆ek. Their work appears in journals such as Journal of Pharmaceutical Sciences, Thrombosis Research, International Journal of Pharmaceutics, Annals of the New York Academy of Sciences and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.